Financials
- Market Capitalization 9.31 B
- Employee 253
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-23.27
Relación precio/flujo de caja
148.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 926 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.96 USD | 0.00% | +0.18% | +0.45% | +30.55% | 9.79 B USD | ||
| 941 | CORT Corcept Therapeutics Incorporated - Common Stock | 88.61 USD | -2.06% | -5.99% | +6.53% | +20.77% | 9.51 B USD | ||
| 979 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 320.81 USD | -2.10% | +0.86% | +21.09% | +515.99% | 8.94 B USD | ||
| 983 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 53.78 USD | -2.09% | -37.02% | -27.26% | -25.44% | 8.89 B USD |